Non-Risk Payments for Second Generation Direct Acting Antivirals for Hepatitis C Sample Clauses

Non-Risk Payments for Second Generation Direct Acting Antivirals for Hepatitis C. The capitation rates do not include the costs of second generation direct acting antivirals (DAAs) for the treatment of hepatitis C as described in Attachment B-1, Section 8.
AutoNDA by SimpleDocs

Related to Non-Risk Payments for Second Generation Direct Acting Antivirals for Hepatitis C

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!